HIGHLIGHTS
- who: Chiara Cattaneo and colleagues from the Hematology Unit, ASST-Spedali Civili, Brescia, Italy University of Cologne, Faculty of Medicine, University Hospital Cologne, Translational Research, Cologne have published the article: Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey, in the Journal: Cancers 2022, 14, 5530. of 11/Oct/2022
- what: Hereby, the authors aimed to assess the overall survival (OS) of patients with simultaneous onset of HM and COVID-19 as primary endpoint of the study. In 151 (85.3%) patients COVID-19 was responsible for death; however, however, in 78 (44%) patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.